To view this email as a web page, click here.
 
TOP STORIES
 
Oncology treatments: Three areas to watch
While targeted cancer therapies make up a big part of the pipeline, there are three areas that oncology experts want you to keep on your radar.
Read more
ADVERTISEMENT
 
FDA challenges abuse-deterrent opioid drug claim
The FDA pushes back on new painkiller's abuse-deterrent claims. Here's why this is important to the opioid epidemic.
Read more
ADVERTISEMENT
 
Four ways health execs can prep for costly CAR-T cell therapies
With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here's how to manage the monetary impact.
Read more
 
survey
 
We’re interested in your insight on clinical decision support strategies. Take our 3-minute survey for a chance to win a $200 gift card.
Take survey
 
DIGITAL EDITION
Check out our latest issue featuring:
 • Organizations plan for 2018 despite policy uncertainty
 • Six ways to curb readmissions
 • Pediatric drug pipeline
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.